AU2003290083A1 - Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin's lymphomas - Google Patents

Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin's lymphomas

Info

Publication number
AU2003290083A1
AU2003290083A1 AU2003290083A AU2003290083A AU2003290083A1 AU 2003290083 A1 AU2003290083 A1 AU 2003290083A1 AU 2003290083 A AU2003290083 A AU 2003290083A AU 2003290083 A AU2003290083 A AU 2003290083A AU 2003290083 A1 AU2003290083 A1 AU 2003290083A1
Authority
AU
Australia
Prior art keywords
iap
lymphomas
hodgkin
diagnosis
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290083A
Inventor
Stephen Jaques Hamilton-Dutoit
Juliane M. Jurgensmeier
Hamid Kashkar
Martin Kronke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Center Cologne GmbH
Original Assignee
Cell Center Cologne GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Center Cologne GmbH filed Critical Cell Center Cologne GmbH
Publication of AU2003290083A1 publication Critical patent/AU2003290083A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003290083A 2002-08-13 2003-07-18 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin's lymphomas Abandoned AU2003290083A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10237139.3 2002-08-13
DE10237139 2002-08-13
PCT/EP2003/007889 WO2004017991A1 (en) 2002-08-13 2003-07-18 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin’s lymphomas

Publications (1)

Publication Number Publication Date
AU2003290083A1 true AU2003290083A1 (en) 2004-03-11

Family

ID=31895549

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290083A Abandoned AU2003290083A1 (en) 2002-08-13 2003-07-18 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin's lymphomas

Country Status (2)

Country Link
AU (1) AU2003290083A1 (en)
WO (1) WO2004017991A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5122275B2 (en) 2004-03-23 2013-01-16 ジェネンテック， インコーポレイテッド Azabicyclo-octane inhibitors of IAP
RU2401840C2 (en) 2004-07-02 2010-10-20 Дженентек, Инк. Iap inhibitors
US20060167066A1 (en) 2004-12-20 2006-07-27 Genentech, Inc. Pyrrolidine inhibitors of IAP
SI2397156T1 (en) * 2005-06-08 2017-06-30 Dana-Farber Cancer Institute, Inc. Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1)pathway
NZ594746A (en) 2005-12-19 2013-03-28 Genentech Inc Inhibitors of iap
CN101605786A (en) 2006-12-19 2009-12-16 健泰科生物技术公司 The imidazopyridine inhibitor of apoptosis inhibitor
TWI432212B (en) 2007-04-30 2014-04-01 Genentech Inc Inhibitors of iap
CN101970495A (en) * 2008-02-20 2011-02-09 德累斯顿工业大学 Use of substances for sensitization of tumor cells to radiation and/or chemotherapy
US8835393B2 (en) 2008-08-02 2014-09-16 Genentech, Inc. Inhibitors of IAP
FI20115640A0 (en) * 2011-06-22 2011-06-22 Turun Yliopisto combination therapy
JP6393682B2 (en) 2012-07-13 2018-09-19 トゥルン イリオピスト Combination therapy III
CA2974651A1 (en) 2014-01-24 2015-07-30 Children's Hospital Of Eastern Ontario Research Institute Inc. Smc combination therapy for the treatment of cancer
CN117599041B (en) * 2024-01-22 2024-05-03 中国人民解放军军事科学院军事医学研究院 Medical application of dehydroequol and derivative thereof as novel radioprotectant and cytoprotectant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133437A (en) * 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases
US6673917B1 (en) * 2000-09-28 2004-01-06 University Of Ottawa Antisense IAP nucleic acids and uses thereof

Also Published As

Publication number Publication date
WO2004017991A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2003233309A1 (en) Absorption body for attachment to the human body
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003252305A1 (en) Composition for preparation for external use on skin and method of using the same
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003290083A1 (en) Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin's lymphomas
AU2003289234A1 (en) Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same
AU2003268295A1 (en) "diagnosis and treatment of infertility"
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2003238046A1 (en) Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer's disease
AU2003237657A1 (en) Means and methods for improved treatment using "setrones"
AU2003245415A1 (en) Vehicle for the medical treatment of persons in remote areas
GB0201025D0 (en) The treatment of degenerative diseases
AU2003206285A1 (en) Unit and arrangement for the treatment of vehicles, where an integrated unit is used
AU2003259689A1 (en) 3-imino-2-indolones for the treatment of depression and/or anxiety
AU2003215725A1 (en) Materials and methods relating to the treatment of lymphoma
AU2003242746A1 (en) Device for cleaning the outer skin of land vehicles and watercrafts

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase